Key result
M2-AABs are detected in 40% of DCM patients and linked to idiopathic AF.
Why the study?
The clinical significance of M2-muscarinic acetylcholine receptor autoantibodies in patients with dilated cardiomyopathy needed to be characterised.
Are M2-muscarinic acetylcholine receptor autoantibodies associated with the development of atrial fibrillation in patients with dilated cardiomyopathy?
Case-Control (n=312)
Are M2-muscarinic acetylcholine receptor autoantibodies associated with the development of atrial fibrillation in patients with dilated cardiomyopathy?
M2-muscarinic acetylcholine receptor autoantibodies are prevalent in patients with dilated cardiomyopathy and idiopathic atrial fibrillation, and may play a mechanistic role in the development of atrial fibrillation.
Answers are grounded in this paper and cite their sources.
M2-AAB testing in DCM remains investigational; leaves open their value as biomarkers or therapeutic targets.
AIM: To characterise the clinical significance of M2-muscarinic acetylcholine receptor autoantibodies (M2-AAB) in patients with dilated cardiomyopathy (DCM). METHODS AND RESULTS: Sera from 104 patients with DCM, age-matched with 104 patients with idiopathic atrial fibrillation (Af) and 104 healthy control subjects, were screened for M2-AAB by enzyme-linked immunosorbent assay (ELISA). IgG purified by Protein-A column was also used as a primary antibody in ELISA. In DCM, M2-AAB were detected in 40% of patients using whole sera and in 36% of patients using purified IgG. M2-AAB were also found in several patients with idiopathic Af (23%, 23%), and these frequencies were significantly higher than those in healthy subjects (8%, 8%). Af was more common in AAB-positive than in AAB-negative patients with DCM. Multivariable analysis confirmed that M2-AAB were independent predictors of the presence of Af in such patients. We determined electrophysiological changes by adding patient purified M2-AAB to chick embryos. Purified IgG from both Af and DCM patients exhibited negative chronotropic effects and induced supraventricular arrhythmias. CONCLUSION: M2-AAB may play a role in mediating the development of Af in patients with DCM.
No takes yet. Share an insight, caveat, or question.
Akiyasu Baba (2004) conducted a case-control in Dilated cardiomyopathy and idiopathic atrial fibrillation (n=312). M2-muscarinic acetylcholine receptor autoantibodies (M2-AAB) vs. Healthy controls was evaluated on Detection of M2-AAB using whole sera. M2-muscarinic acetylcholine receptor autoantibodies were detected in 40% of patients with dilated cardiomyopathy and 23% with idiopathic atrial fibrillation, compared to 8% of healthy controls.
Synapse has enriched 10 related papers. Consider them for comparative context: